The Powell Perspective

As the U.S. housing crisis deepens, Safehold's Ivory Prize nomination highlights how innovative finance can build a new foundation for affordability.

With BRINSUPRI revenues set to hit $1B, Insmed is pouring cash into a high-stakes pipeline. Can it outrun its massive burn rate to deliver the next breakthrough?

With major grants from top foundations, Lario Therapeutics expands its precision neuroscience platform, offering new hope for complex neurological disorders.

With two new communities in San Tan Valley and Buckeye, the national homebuilder meets demand for affordable housing in Phoenix's stabilizing market.

A major expansion by MAX Surgical Specialty Management adds three top oral surgeons, signaling a strategic shift in New Jersey's healthcare landscape.

Logile launches a new podcast to demystify retail operations, exploring how AI and workforce strategies can drive real-world ROI for industry leaders.

Olympia Pharmaceuticals unveils Circulate, a single-dose IV premix blending science and efficiency to support vascular health and streamline clinic operations.

With a clean security review, NatGold's plan to tokenize in-ground gold gains credibility, but can its ambitious vision reshape the future of money?

Bausch + Lomb beats Q4 revenue forecasts, propelled by its blockbuster dry eye drug MIEBO, and issues a confident financial outlook for 2026.

The car wash giant celebrates a record year by announcing a take-private deal with Leonard Green & Partners, signaling a new era of aggressive growth.

As Bimergen Energy prepares for its NYSE American listing, its move highlights the critical role of battery storage in the energy transition and what it means for investors.

Data storage firm Quantum posts a surprise Q3 revenue beat and improved profits, but can its AI strategy and debt overhaul secure a long-term future?

The Vilcek Foundation is offering six $50,000 awards to young immigrant chefs, writers, and artisans who are shaping the future of American cuisine.

With key promotions, ESI reinforces its vertically integrated model, leveraging decades of expertise to capitalize on a booming structural steel market.

Celebrating 100 years, WIDIA reflects on its revolutionary past while navigating a future of AI, automation, and a persistent skilled labor shortage.

Eagle Point Credit Co. slashes its dividend after reporting major losses but counters with a $100M buyback and a strategic shift beyond CLO equity.

Watchmaker Genomics is repurposing CRISPR, not for editing genes, but to make DNA sequencing faster, cheaper, and more reliable than ever before.

Amidst a volatile stock history, GT Biopharma aims to secure vital funding for its innovative NK cell therapy pipeline at a key Toronto conference.

A new partnership gives UnionPay cardholders access to 13,000 UK ATMs, a strategic move to capture high-value tourist spending and reinforce cash's role.

New long-term data shows duvakitug maintained remission in IBD patients for nearly a year, positioning it as a top contender in a new class of therapy.